Exercise training and immune crosstalk in breast cancer microenvironment: Exploring the paradigms of exercise-induced immune modulation and exercise-induced myokines

American Journal of Translational Research

Volumn 6, Issue 5, 2014, Pages 422-438

  Goh, Jorming ^a   Niksirat, Negin ^b   Campbell, Kristin L ^b  

^a DSO NATIONAL LABORATORIES   (Singapore)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Breast cancer; Exercise; Immune; Immunotherapy; Myokines; Translational

Indexed keywords

BIOLOGICAL FACTOR; BIOLOGICAL MARKER; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 4; INTERLEUKIN 6; MYOKINE; ONCOSTATIN M; OSTEONECTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AEROBIC EXERCISE; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVOR; HUMAN; IMMUNITY; IMMUNOMODULATION; INFLAMMATION; MACROPHAGE; MONOCYTE; NONHUMAN; PROTECTION; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT;

EID: 84908063151     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Speck RM, Courneya KS, Mâsse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010; 4: 87-100.
2. Friedenreich CM, Neilson HK. State of the epi­demiological evidence on physical activity and cancer prevention. Eur J Cancer 2010; 46: 2593-2604.
3. Loprinzi PD, Cardinal BJ, Winters-Stone K, Smit E, Loprinzi CL. Physical activity and the risk of breast cancer recurrence: a literature review. Oncol Nurs For 2012; 39: 269-274.
4. Schmidt ME, Chang-Claude J, Vrieling A, Sei­bold P, Heinz J, Obi N, Flesch-Janys D, Stein­dorf K. Association of pre-diagnosis physical activity with recurrence and mortality among women with breast cancer. Int J Cancer 2013; 133: 1431-1440.
5. Sternfeld B, Weltzien E, Quesenberry CP Jr, Castillo AL, Kwan M, Slattery ML, Caan BJ. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study. Cancer Epidemiol Bio­markers Prev 2009; 18: 87-95.
6. Ballard-Barbash R, Friedenreich CM, Courneya KS, Siddiqi SM, McTiernan A, Alfano CM. Physi­cal activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst 2012; 104: 815-840.
7. Campbell KL, McTiernan A. Exercise and bio­markers for cancer prevention studies. J Nutr 2007; 137: 161S-169S.
8. Koivisto VA, Soman V, Conrad P, Hendler R, Nadel E, Felig P. Insulin binding to monocytes in trained athletes: changes in the resting state and after exercise. J Clin Invest 1979; 64: 1011-1015.
9. McCarthy DA, Perry JD, Melsom RD, Dale MM. Leukocytosis induced by exercise. Br Med J 1987; 295: 636.
10. Nieman DC, Johanssen LM, Lee JW. Infectious episodes in runners before and after a roadra­ce. J Sports Med Phys Fitness 1989; 29: 289-296.
11. Nieman DC, Cook VD, Henson DA, Suttles J, Rejeski WJ, Ribisl PM, Fagoaga OR, Nehlsen-Cannarella SL. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int J Sports Med 1995; 16: 334-337.
12. Pedersen BK. Exercise-induced myokines and their role in chronic disease. Brain Behav Im­mun 2011; 25: 811-816.
13. Aoi W, Naito Y, Takagi T, Tanimura Y, Takanami Y, Kawai Y, Sakuma K, Hang LP, Mizushima K, Hirai Y, Koyama R, Wada S, Higashi A, Kokura S, Ichikawa H, Yoshikawa T. A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 2013; 62: 882-889.
14. Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM. A PGC-1α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-468.
15. Broholm C, Mortensen OH, Nielsen S, Aker­strom T, Zankari A, Dahl B, Pedersen BK. Exer­cise induces expression of leukaemia inhibito­ry factor in human skeletal muscle. J Physiol 2008; 586: 2195-2201.
16. Mortensen OH, Andersen K, Fischer C, Nielsen AR, Nielsen S, Akerström T, Aastrøm MB, Borup R, Pedersen BK. Calprotectin is released from human skeletal muscle tissue during exercise. J Physiol 2008; 586; 3551-3562.
17. Quinn LS, Anderson BG, Strait-Bodey L, Stroud AM, Argilés JM. Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am J Physiol Endocrinol Metab 2009; 296: E191-E202.
18. Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW. Myonectin (CTRP15), a novel myo­kine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 2012; 287: 11968-11980.
19. Mukhtar RA, Nseyo O, Campbell MJ, Esserman LJ. Tumor-associated macrophages in breast cancer as potential biomarkers for new treat­ments and diagnostics. Expert Rev Mol Diagn 2011; 11: 91-100.
20. Campbell MJ, Tonlaar NY, Garwood ER, Huo D, Moore DH, Khramtsov AI, Au A, Baehner F, Chen Y, Malaka DO, Lin A, Adeyanju OO, Li S, Gong C, McGrath M, Olopade OI, Esserman LJ. Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome. Breast Can­cer Res Treat 2011; 128: 703-11.
21. Heusinkveld M, Van Der Burg S. Identification and manipulation of tumor associated macro­phages in human cancers. J Transl Med 2011; 9: 216.
22. Laoui D, Movahedi K, Van Overmeire E, Van den Bossche J, Schouppe E, Mommer C, Niko­laou A, Morias Y, De Baetselier P, Van Ginder­achter JA. Tumor-associated macrophages in breast cancer: distinct subsets, distinct func­tions. Int J Dev Biol 2011; 55: 861-867.
23. DeMarco RA, Fink MP, Lotze MT. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1. Mol Immunol 2005; 42: 433-444.
24. Watkins SK, Li B, Richardson KS, Head K, Egil­mez NK, Zeng Q, Suttles J, Stout RD. Rapid re­lease of cytoplasmic IL-15 from tumor associ­ated macrophages is an initial and critical event in IL-12 initiated tumor regression. Eur J Immunol 2009; 39: 2126-2135.
25. Hagemann T, Lawrence T, McNeish I, Charles KA, Kulbe H, Thompson RG, Robinson SC, Balkwill FR. “Re-educating” tumor-associated macrophages by targeting NF-kappaB. J Exp Med 2008; 205: 1261-1268.
26. Emtage PC, Clarke D, Gonzalo-Daganzo R, Junghans RP. Generating potent Th/Tc1 T cell adoptive immunotherapy doses using human IL-12: harnessing the immunomodulatory po­tential of IL-12 without the in vivo associated toxicity. J Immunother 2003; 26: 97-106.
27. Tsung K, Dolan JP, Tsung YL, Norton JA. Macro­phages as effector cells in interleukin 12-in­duced T cell-dependent tumor rejection. Can­cer Res 2002; 62: 5069-5075.
28. Comes A, Di Carlo E, Musiani P, Rosso O, Meaz­za R, Chiodoni C, Colombo MP, Ferrini S. IFN-gamma-independent synergistic effects of IL-12 and IL-15 induce anti-tumor immune responses in syngeneic mice. Eur J Immunol 2002; 32: 1914-1923.
29. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J, Harris AL. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996; 56: 4625-4629.
30. Menetrier-Caux C, Faget J, Biota C, Gobert M, Blay JY, Caux CL. Innate immune recognition of breast tumor cells mediates CCL22 secretion favoring Treg recruitment within tumor environ­ment. OncoImmunol 2012; 1: 759-761.
31. Ma J, Liu L, Che G, Yu N, Dai F, You Z. The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC Cancer 2010; 10: 112.
32. Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Macrophages within NSCLC tu­mour islets are predominantly of a cytotoxic M1 phenotype associated with extended sur­vival. Eur Respir J 2009; 33: 118-126.
33. Kilinc MO, Aulakh KS, Nair RE, Jones SA, Alard P, Kosiewicz MM, Egilmez NK. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apop­tosis, and infiltration of CD8+ T effectors. J Im­munol 2006; 177: 6962-73.
34. + T cells display enhanced antitumor im­munity. Blood 2009; 114: 596-599.
35. Lee HJ, Seo JY, Ahn JH, Ahn SH, Gong G. Tumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patients. J Breast Cancer 2013; 16: 32-39.
36. Song G, Wang X. Elevated level of peripheral CD8+CD28-T lymphocytes are an independent predictor of progression-free survival in pa­tients with metastatic breast cancer during the course of chemotherapy. Cancer Immunol Im­munother 2013; 62: 1123-1130.
37. West NR, Milne K, Truong PT, Macpherson N, Nelson BH, Watson PH. Tumor-infiltrating lym­phocytes predict response to anthracycline-based chemotherapy in estrogen receptor-neg­ative breast cancer. Breast Cancer Res 2011; 13: R126.
38. Feng AL, Zhu JK, Sun JT, Yang MX, Neckenig MR, Wang X., Shao QQ, Song BF, Yang QF, Kong BH, Qu X. CD16+ monocytes in breast cancer patients: expanded by monocyte che­moattractant protein-1 and may be useful for early diagnosis. Clin Exp Immunol 2011; 164: 57-65.
39. Coussens LM, Werb Z. Inflammation and can­cer. Nature 2002; 420: 860-867.
40. Field CJ, Gougeon R, Marliss EB. Circulating mononuclear cell numbers and function dur­ing intense exercise and recovery. J Appl Physi­ol 1991; 71: 1089-1097.
41. Gabriel H, Schwarz L, Born P, Kindermann W. Differential mobilization of leucocyte and lym­phocyte subpopulations into the circulation during endurance exercise. Eur J Appl Physiol Occup Physiol 1992; 65: 529-534.
42. Michel G, Vocke T, Fiehn W, Weicker H, Schwarz W, Bieger WP. Bidirectional alteration of insulin receptor affinity by different forms of physical exercise. Am J Physiol 1984; 246: E153-E159.
43. Tvede N, Pedersen BK, Hansen FR, Bendix T, Christensen LD, Galbo H, Halkjaer-Kristensen J. Effect of physical exercise on blood mono­nuclear cell subpopulations and in vitro prolif­erative responses. Scand J Immunol 1989; 29: 383-389.
44. Ratge D, Wiedemann A, Kohse KP, Wisser H. Alterations of beta-adrenoceptors on human leukocyte subsets induced by dynamic exer­cise: effect of prednisone. Clin Exp Pharmacol Physiol 1988; 15: 43-53.
45. Scharhag J, Meyer T, Gabriel HH, Schlick B, Faude O, Kindermann W. Does prolonged cy­cling of moderate intensity affect immune cell function? Br J Sports Med 2005; 39: 171-177.
46. Gabriel H, Urhausen A, Brechtel L, Müller HJ, Kindermann W. Alterations of regular and ma­ture monocytes are distinct, and dependent on intensity and duration of exercise. Eur J Appl Physiol Occup Physiol 1994; 69: 179-181.
47. Steppich B, Dayyani F, Gruber R, Lorenz R, Mack M, Ziegler-Heitbrock HW. Selective mobi­lization of CD14+CD16+ monocytes by exercise. Am J Physiol 2000; 279: C578-C586.
48. Zaldivar F, Wang-Rodriguez J, Nemet D, Schwindt C, Galassetti P, Mills PJ, Wilson LD, Cooper DM. Constitutive pro-and anti-inflam­matory cytokine and growth factor response to exercise in leukocytes. J Appl Physiol 2006; 100: 1124-113.
49. Gabriel H, Rothe G, Korpys M, Schmitz G, Kin­dermann W. Enhanced expression of HLA-DR, Fc gamma receptor 1 (CD64) and leukocyte common antigen (CD45) indicate activation of monocytes in regenerative training periods of endurance athletes. Int J Sports Med 1997; 18: 136-141.
50. Timmerman KL, Flynn MG. Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflamma­tory influence of exercise? J Leukol Biol 2008; 84: 1271-1278.
51. Peters C, Lötzerich H, Niemeir B, Schüle K, Uhlenbruck G. Exercise, cancer and the im­mune response of monocytes. Anticancer Res 1995; 15: 175-179.
52. Gomez AM, Martinez C, Fiuza-Luces C, Herrero F, Pérez M, Madero L, Ruiz JR, Lucia A, Ramírez M. Exercise training and cytokines in breast cancer survivors. Int J Sports Med 2011; 32: 461-467.
53. Lötzerich H, Fehr HG, Appell HJ. Potentiation of cytostatic but not cytolytic activity of murine macrophages after running stress. Int J Sports Med 1990; 11: 61-65.
54. Woods JA, Davis JM, Mayer EP, Ghaffar A, Pate RR. Exercise increases inflammatory macro­phage antitumor cytotoxicity. J Appl Physiol 1993; 75: 879-886.
55. Woods JA, Davis JM, Mayer EP, Ghaffar A, Pate RR. Effects of exercise on macrophage activa­tion for antitumor cytotoxicity. J Appl Physiol 1994; 76: 2177-2185.
56. Goh J, Kirk EA, Lee SX, Ladiges WC. Exercise, physical activity and breast cancer: the role of tumor-associated macrophages. Exerc Immu­nol Rev 2012; 18: 158-176.
57. Wang B, Li Q, Qin L, Zhao S, Wang J, Chen X. Transition of tumor-associated macrophages from MHC class II (hi) to MHC class II (low) me­diates tumor progression in mice. BMC Immu­nol 2011; 12: 43.
58. Nieman DC, Miller AR, Henson DA, Warren BJ, Gusewitch G, Johnson RL, Davis JM, Butter­worth DE, Herring JL, Nehlsen-Cannarella SL. Effect of high-versus moderate-intensity exer­cise on lymphocyte subpopulations and prolif­erative response. Int J Sports Med 1994; 15: 199-206.
59. Mitchell JB, Paquet AJ, Pizza FX, Starling RD, Holtz RW, Grandjean PW. The effect of moder­ate aerobic training on lymphocyte prolifera­tion. Int J Sports Med 1996; 17: 384-389.
60. Handzlik MK, Shaw AJ, Dungey M, Bishop NC, Gleeson M. The influence of exercise training status on antigen-stimulated IL-10 production in whole blood culture and numbers of circulat­ing regulatory T cells. Eur J Appl Physiol 2013; 113: 1839-1848.
61. Goh J, Tsai J, Bammler TK, Farin FM, Endicott EE, Ladiges WC. Exercise training in transgenic mice is associated with attenuation of early breast cancer growth in a dose-dependent manner. PLoS One 2013; 8: e80123.
62. Mathur N, Pedersen BK. Exercise as a mean to control low-grade systemic inflammation. Me­diators Inflamm 2008; 2008: 109502.
63. Pedersen BK. A muscular twist on the fate of fat. N Engl J Med 2012; 366: 1544-1545.
64. Hojman P, Dethlefsen C, Brandt C, Hansen J, Pedersen L, Pedersen BK. Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Endocrinol Metab 2011; 301: E504-E510.
65. Steensberg A, Fischer CP, Keller C, Møller K, Pedersen BK. IL-6 enhances plasma IL-1ra, IL-10 and cortisol in humans. Am J Physiol Endo­crinol Metab 2003; 285: E433-E437.
66. Kawanishi N, Yano H, Yokogawa Y, Suzuki K. Exercise training inhibits inflammation in adi­pose tissue via both suppression of macro­phage infiltration and acceleration of pheno­typic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice. Exerc Immu­nol Rev 2010; 16: 105-118.
67. Inoue M, Senju S, Hirata S, Ikuta Y, Hayashida Y, Irie A, Harao M, Imai K, Tomita Y, Tsunada T, Furukawa Y, Ito T, Nakamura Y, Baba H, Nishimura Y. Identification of SPARC as a can­didate target antigen for immunotherapy of various cancers. Int J Cancer 2010; 127: 1393-1403.
68. Segat L, Milanese M, Pirulli D, Trevisiol C, Lupo F, Salizzoni M, Amoroso A, Crovella S. Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepato­cellular carcinoma in Italian patients. J Gastro­enterol Hepatol 2009; 24: 1840-1846.
69. Ostrowski K, Hermann C, Bangash A, Schjer­ling P, Nielsen JN, Pedersen BK. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J Physiol 1998; 513: 889-894.
70. Tamura Y, Watanabe K, Kantani T, Hayashi J, Ishida N, Kaneki M. Upregulation of circulating IL-15 by treadmill running healthy individuals: is IL-15 an endocrine mediator of the benefi­cial effects of endurance exercise? Endocr J 2011; 58: 211-215.
71. Campbell PT, Campbell KL, Wener MH, Wood BL, Potter JD, McTiernan A, Ulrich CM. A year­long exercise intervention decreases CRP among obese postmenopausal women. Med Sci Sports Exerc 2009; 41: 1533-1539.
72. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackey JR. Randomized controlled trial of exercise and blood immune function in post­menopausal breast cancer survivors. J Appl Physiol 2005; 98: 1534-1540.
73. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Martin BS, Mackey JR. Effect of exercise training on C-reactive protein in postmeno­pausal breast cancer survivors: A randomized controlled trial. Brain Behav Immun 2005; 19: 381-388.
74. Arikawa AY, Thomas W, Schmitz KH, Kurzer MS. Sixteen weeks of exercise reduces C-reac­tive protein levels in young women. Med Sci Sports Exerc 2011; 43: 1002-1009.
75. Horne L, Bell G, Fisher B, Warren S, Janowska-Wieczorek A. Interaction between cortisol and tumour necrosis factor with concurrent resis­tance and endurance training. Clin J Sport Med 1997; 7: 247-251.
76. Jimenez C, Melin B, Savourey G, Launay JC, Alonso A, Mathieu J. Effects of passive hyper­thermia versus exercise-induced hyperthermia on immune responses: Hormonal implications. Eur Cytokine Netw 2007; 18: 154-161.
77. Nehlsen-Cannarella SL, Nieman DC, Balk-Lam­berton AJ, Markoff PA, Chritton DB, Gusewitch G, Lee JW. The effects of moderate exercise training on immune response. Med Sci Sports Exerc 1991; 23: 64-70.
78. Campbell KL, Campbell PT, Ulrich CM, Wener M, Alfano CM, Foster-Schubert K, Rudolph RE, Potter JD, McTiernan A. No reduction in C-reac­tive protein following a 12-month randomized controlled trial of exercise in men and women. Cancer Epidemiol Biomarkers Prev 2008; 17: 1714-1718.
79. Friedenreich CM, Neilson HK, Woolcott CG, Wang Q, Stanczyk FZ, McTiernan A, Jones CA, Irwin ML, Yasui Y, Courneya KS. Inflammatory marker changes in a yearlong randomized ex­ercise intervention trial among postmenopaus­al women. Cancer Prev Res 2012; 5: 98-108.
80. Imayama I, Ulric CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, Mctier­nan A. Effects of a caloric restriction weight loss diet and exercise on inflammatory bio­markers in overweight/obese postmenopaus­al women: A randomized controlled trial. Can­cer Res 2012; 72: 2314-2326.
81. Lee MG, Park KS, Kim DU, Choi SM, Kim HJ. Effects of high-intensity exercise training on body composition, abdominal fat loss, and car­diorespiratory fitness in middle-aged korean females. Appl Physiol Nutr Metab 2012; 37: 1019-1027.
82. Ergun M, Eyigor S, Karaca B, Kisim A, Uslu R. Effects of exercise on angiogenesis and apop­tosis-related molecules, quality of life, fatigue and depression in breast cancer patients. Eur J Cancer Care 2013; 22: 626-37.
83. Jones SB, Thomas GA, Hesselsweet SD, Alva­rez-Reeves M, Yu H, Irwin ML. Effect of exercise on markers of inflammation in breast cancer survivors: The yale exercise and survivorship study. Cancer Prev Res 2013; 6: 109-118.
84. Payne JK, Held J, Thorpe J, Shaw H. Effect of exercise on biomarkers, fatigue, sleep distur­bances, and depressive symptoms in older women with breast cancer receiving hormonal therapy. Oncol Nurs Forum 2008; 35: 635-642.
85. Sprod LK, Janelsins MC, Palesh OG, Carroll JK, Heckler CE, Peppone LJ, Mohile SG, Morrow GR, Mustian KM. Health-related quality of life and biomarkers in breast cancer survivors par­ticipating in tai chi chuan. J Cancer Surviv 2012; 6: 146-154.
86. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2. The Cochrane Collaboration 2009.